The application value of time-zero renal biopsy in living donor kidney transplantation
10.16571/j.cnki.1008-8199.2018.07.015
- VernacularTitle: 供肾零点活检在活体肾移植中的应用价值
- Author:
Bing YOU
1
;
Ping LI
1
;
Ji-qiu WEN
1
;
Dong-rui CHENG
1
;
Ke-nan XIE
1
;
Xue LI
1
;
Xue-feng NI
1
;
Jin-song CHEN
1
Author Information
1. National Clinical Research Center of Kidney Diseases, Jinling Hospital, Medical School of Nanjing University/Nanjing General Hospital of Nanjing Military Region, PLA, Nanjing 210002, Jiangsu, China
- Publication Type:Journal Article
- Keywords:
living donor kidney;
kidney transplantation;
time-zero renal biopsy
- From:
Journal of Medical Postgraduates
2018;31(7):739-744
- CountryChina
- Language:Chinese
-
Abstract:
Objective Few studies have paid attention to time-zero renal biopsy in living kidney transplantation so far. This article aimed to investigate the risk factors of latent pathologic changes in living donors by time-zero renal biopsy (TO-RBx) and the predictive value in the allograft function of recipients early after living kidney transplantation.Methods We retrospectively analysed the clinical data of 89 renal transplant recipients and living donors who received TO-RBx at Nanjing General Hospital from January 2008 to December 2016. According to the 2007 Banff criteria, the common pathologic changes in living donors such as latent glomeruloscerosis (GS), tubular atrophy (CT), interstitial fibrosis (CI), arteriolar hyaline thickening (AH) and vascular fibrous intimal thickening (CV) were scored. To analyze the influencing factors for different pathological changes and evaluate its predictive value in the allograft function of recipients in 1, 3, 6 months after living renal transplantation.Results Of all the TO-RBx specimens, 23 cases (25.84%) with GS (21 were mild change, 1 was moderate change and 1 was severe change), 33 cases (37.08%) with CT/CI changes (30 were mild change and 3 were moderate change) and 37 cases (41.57%) with AH/CV changes (36 were mild change and 1 was moderate change). GS was related to the donor age (P=0.042); CT/CI changes were related to donor age, gender and systolic pressure (P=0.019；0.006；0.01); arterial changes were related to donor gender and blood triglyceride level (P=0.029；0.049). Within 3 and 6 months after living donor renal transplantation, the eGFR of renal transplant recipients with GS lesions \[(65.96±17.17), (69.52±19.1)mL/min·1.73m2\] were significantly lower than the groups without lesions \[(76.91±18.98), (79.52±18.91)mL/min·1.73m2\] (P＜0.05).Conclusion Time-zero renal biopsy has significance in terms of predicting the allograft function in 6 months after transplantation. It can guide the formulation and adjustment of postoperative immunosuppressive regimens for recipients. Besides, it can also detect the latent pathologic changes in living donors and is one of the important evidence for establishing a personalized follow-up plan for donors after surgery. This method is practical in clinical.
